Revolutionizing Anesthesia: Personalized Monitoring with Photoacoustic Technology

The Promise of Photoacoustic Measurement Devices in Anesthesia Monitoring In the realm of medicine, individual patient factors such as body weight and pre-existing conditions significantly influence the efficacy of drugs. This is especially true in the operating room, where anesthetic management is crucial for patient safety. The accurate dosing of anesthetics like propofol is vital; incorrect dosing can lead to severe consequences, including intraoperative awareness during surgery. In Germany alone, it is estimated that there are approximately 16,000 cases of intraoperative awareness each year (Bischoff & Rundshagen, 2011). Researchers at the Fraunhofer Institute for Building Physics IBP, in collaboration with LMU Munich, are working on a groundbreaking solution: a photoacoustic detector designed to enable continuous real-time monitoring of propofol levels during clinical operations. Real-Time Monitoring of Anesthetics Propofol is one of the most widely used anesthetics in the field of anesthesia. It acts quickly, prevents postoperative nausea, and does not contribute to greenhouse gas emissions. However, the therapeutic range—that is, the narrow margin between under- and overdosing—poses significant challenges in its administration. Currently, monitoring the depth of anesthesia relies mainly on indirect methods. The photoacoustic detector proposes a novel approach by measuring the anesthetic directly from the exhaled breath of patients. Kevin Haas, the patent manager at Fraunhofer IBP, states, 'While the depth of anesthesia is primarily monitored indirectly, we are pursuing a different approach by measuring the anesthetic directly in the exhaled air.' This innovative method, based on the acoustic and sensor technology expertise of Fraunhofer IBP, lays the groundwork for more precise and patient-specific monitoring of anesthesia. Limitations of EEG Monitoring Currently, the depth of anesthesia is predominantly assessed using EEG (electroencephalography) monitoring, which measures electrical activity in the brain. However, EEG-derived indices can be influenced by analgesics and muscle relaxants. A study conducted in 2025 by LMU and IBP found that the propofol dosage had to be adjusted an average of 13 times in eight out of ten patients, even when EEG readings indicated adequate sedation. The Importance of Accurate Dosage Misadministration of propofol can have serious ramifications. An overdose risks hypotension, respiratory distress, and cardiac arrest, while underdosing could result in unexpected awakening during surgical procedures. The risk of intraoperative awareness is not uniformly distributed among patients; it is significantly higher in children and high-risk individuals such as trauma patients (Pilge & Schneider, 2013). Moreover, women are more frequently affected than men, and the risk escalates during emergency surgeries, cesarean sections, and cardiac procedures. Challenges with Existing Monitoring Methods Various breathing air monitoring techniques to determine propofol levels have been explored but have yet to gain traction in clinical practice. Mass spectrometry, regarded as the gold standard for measuring low propofol concentrations, is impractical due to its size, high cost, and maintenance requirements. An earlier attempt using ion mobility spectrometry (MCC-IMS) was ineffective because moisture in patients' breath significantly interfered with measurements (Teucke et al., 2022). In contrast, the photoacoustic prototype has been specifically designed for clinical use and has been tested in clinical studies at LMU Munich. It efficiently measures low propofol concentrations while being compact, cost-effective, and requiring minimal maintenance. Next Steps Toward Clinical Implementation Three additional optimized prototypes are currently being developed at Fraunhofer IBP to further validate the methodology and system. The institute is also developing a mobile calibration device that the future manufacturer can use to calibrate the instrument. An international market launch of the propofol detector is planned by 2030. Conclusion The ongoing efforts to advance photoacoustic measurement technology could revolutionize anesthesia monitoring, providing clinicians with innovative tools for ensuring patient safety and comfort during surgical procedures. Improved methods of monitoring will not only enhance precision in drug administration but might also lower the incidence of intraoperative awareness, marking a significant milestone in anesthesiology. With continuous advancements and validation, the future of anesthesia monitoring looks promising.